Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00399165 · ClinicalTrials.gov registry record · Phase 1
Oral Androgens in Man-4: (Short Title: Oral T-4)
A Phase 1 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT00399165 is a Phase 1 study that has completed, run by University of Washington. The registered enrollment target is 20 participants.
The verdict
NCT00399165, a Phase 1 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
The protocol was designed to address the hypothesis that oral testosterone enanthate plus dutasteride can suppress the secretion of LH and FSH after four weeks of administration. In addition, we will compare the gonadotropin suppression mediated by a dose of testosterone enanthate (400 mg twice daily) that would be expected to maintain the serum testosterone in the normal range throughout the day, with the same dose (800 mg once daily) administered once daily. This larger once-daily dose is expected to result in a higher peak and lower trough by the end of the dosing interval
Interventions
- DRUG Testosterone Enanthate
- DRUG Dutasteride
- OTHER placebo sesame oil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2006-11 |
| Est. Completion | 2007-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00399165
The ClinicalTrials.gov registry entry for NCT00399165 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Testosterone Enanthate is the first listed.
NCT00399165 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00399165 about?
NCT00399165 is a clinical study titled "Oral Androgens in Man-4: (Short Title: Oral T-4)". The protocol was designed to address the hypothesis that oral testosterone enanthate plus dutasteride can suppress the secretion of LH and FSH after four weeks of administration. In addition, we will compare the gonadotropin suppression mediated by a dose of testosterone enanthate (400 mg twice dail...
What is the current status of trial NCT00399165?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2006-11. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00399165?
The interventions under investigation include: Testosterone Enanthate (DRUG), Dutasteride (DRUG), placebo sesame oil (OTHER).
Who is sponsoring clinical trial NCT00399165?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.